Allogene Therapeutics Inc (ALLO)
CapEx to Revenue
3.23%
Quarterly · Period ending:
ALLO CapEx to Revenue
Latest reported3.23%period ending
Latest reported3.23%period ending
ALLO Quarterly CapEx/Revenue (0.00% → 3.23%)
Latest values, visible window
High-resolution chart · PNG
ALLO capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 3.2328% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 36.3636% | |
| -411.3636% | |
| 54.5455% | |
| 1,309.0909% | |
| 3,450% | |
| 3,600% | |
| 455.102% | |
| 1,597.6744% | |
| 3,118.0328% | |
| 1,443.1373% | |
| 6,830.6122% | |
| 24,777.2727% | |
| 16.8497% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |